Half-year report · HY
7133.TEDINET S100X2MF
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥10.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥226m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥449m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥206m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥205m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥136m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥719m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥136m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥8.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥7.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥6.9bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥754m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥566m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥754m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥566m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥889m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥688m | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥134m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥771m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥527m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥474m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥849m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥419m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥201m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥19.1 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.12 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.03 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥18.55 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥97.92 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.62 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.7% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥373,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥373,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥298m |
| Home Visit Pharmacist Servicereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.9bn |
| Home Visit Pharmacist Servicereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.9bn |
| Home Visit Pharmacist Servicereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥228m |
| Kirari Primereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥591m |
| Kirari Primereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥591m |
| Kirari Primereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥342m |
| Primary Care Homereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Primary Care Homereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Primary Care Homereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥28m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥5.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥5.5bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥542m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥524m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥296m |
| Home Visit Pharmacist Servicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| Home Visit Pharmacist Servicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| Home Visit Pharmacist Servicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥277m |
| Kirari Primereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥544m |
| Kirari Primereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥544m |
| Kirari Primereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥338m |
| Primary Care Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥759m |
| Primary Care Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥759m |
| Primary Care Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥134m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥749m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥745m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 455
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 900000 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.1262 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 840000 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.1178 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 699000 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0981 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 500000 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0701 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 216000 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0302 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 199000 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0279 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 197000 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0276 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 188000 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0264 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 158000 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0221 | |
| Number of shares held | InterimInstant | 5256000 | |
| Shareholding ratio | InterimInstant | 0.7371 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 147100 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 71274 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 7127400 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 3300 | |
| Number of shares issued shares voting rights | InterimInstant | 7277800 | |
| Number of voting rights issued shares voting rights | InterimInstant | 71274 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 147100 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 147100 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0202 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 147100 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 147100 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0202 | |
| Cash and deposits | Prior1YearInstant | 565926000 | JPY |
| Cash and deposits | InterimInstant | 754228000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 1873232000 | JPY |
| Accounts receivable trade | InterimInstant | 2284923000 | JPY |
| Merchandise | Prior1YearInstant | 161307000 | JPY |
| Merchandise | InterimInstant | 224520000 | JPY |
| Other ca | Prior1YearInstant | 102673000 | JPY |
| Other ca | InterimInstant | 121597000 | JPY |
| Current assets | Prior1YearInstant | 2703139000 | JPY |
| Current assets | InterimInstant | 3385271000 | JPY |
| Buildings net | Prior1YearInstant | 2589673000 | JPY |
| Buildings net | InterimInstant | 2656087000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |